CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

LIC MF Healthcare Fund-Reg(G)

very highequitypharma & health care
24.11 0.23(0.96%) NAV as on 25 Apr 2024
3.06 % 1 M
47.53 % 1 Y
11.21 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. However there can be no assurance that the investment objective under the scheme will be realized.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.44

As on 31 Mar, 2024
age-icon Age :

5 yrs 1 m

Since 28 02 ,2019
exit_load Exit Load :

0%

aum AUM :

61.69 Crs

lock_in Lock-in :

Nil upto 12% of units and 1% for remaining units on or before 90D, Nil after 90D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.49

Min_Investment Min. Investment :

SIP 1000 & Lumpsum 5000

Scheme_benchmark Scheme Benchmark :

S&P BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Karan Doshi

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2024
Others 5.02 %
Equity 94.98 %

TOP HOLDINGS

Sun Pharmaceutical Industries...14.88 %
Zydus Lifesciences Ltd.7.46 %
JB Chemicals & Pharmaceuticals...6.27 %
Piramal Pharma Ltd.5.78 %
Cipla Ltd.5.71 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs75.16
Hospital & Healthcare Services16.21
Business Support3.61
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)10.0816.2017.9915.8323.71
Net Assets(Rs Crores) (as on 31-Mar-2024) 26.75 64.43 68.30 49.62 61.69
Scheme Returns(%)(Absolute)0.0063.1410.37-12.0149.49
B'mark Returns(%)(Absolute)NANANANANA
Category Rank5/7556/7552/7572/7630/90

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

LIC MF Healthcare Fund-Reg(G)Very HighEquity24.110.23(0.96%)NAV As on 25 Apr, 202428-Feb-2019Inception Date61.69AUM In Cr.47.53%1Y11.21%3Y18.96%5Y18.60%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity30.660.36(1.19%)NAV As on 25 Apr, 202413-Jul-2018Inception Date3,772.32AUM In Cr.58.94%1Y17.88%3Y24.49%5Y21.35%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity343.652.81(0.82%)NAV As on 25 Apr, 202414-Jul-1999Inception Date2,626.34AUM In Cr.53.91%1Y17.73%3Y23.10%5Y16.10%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity25.050.29(1.19%)NAV As on 25 Apr, 202428-Dec-2015Inception Date878.70AUM In Cr.53.10%1Y16.35%3Y22.08%5Y11.65%Since Inception
DSP Healthcare Fund-Reg(G)Very HighEquity32.220.20(0.64%)NAV As on 25 Apr, 202430-Nov-2018Inception Date2,352.32AUM In Cr.49.84%1Y16.22%3Y25.28%5Y24.18%Since Inception
Nippon India Pharma Fund(G)Very HighEquity427.184.56(1.08%)NAV As on 25 Apr, 202405-Jun-2004Inception Date7,125.28AUM In Cr.52.35%1Y16.03%3Y22.67%5Y20.76%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.